Other informations about the equity market according to article 50 WpHG
Venlo (pta020/08.11.2024/12:15 UTC+1)
Release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution. Post-admission Duties announcement according to Article 50 Para. 1, No. 2 of the WpHG.
Change in Certifying Accountant
On October 31, 2024, the Company executed an engagement letter with EY GmbH & Co. KG Wirtschaftsprüfungsgesellschaft (EY) to engage EY as its independent registered public accounting firm for the year ended December 31, 2025. In connection with this engagement, the Company has dismissed its current independent registered public accounting firm, KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG), effective upon the completion of its audit of the Company's financial statements for the year ended December 31, 2024, at which time KPMG will have reached the maximum aggregate term as the Company's external auditor permitted by Dutch law. The Company's decision to make the change in auditor was due solely to the mandatory audit firm rotation requirement under Dutch law and not due to any disagreement with KPMG.
The Company will provide the additional disclosures in accordance with Item 16F regarding the predecessor accountant in its Form 20-F for the year ending December 31, 2024.
(end)
Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
---|---|---|
Contact Person: | Investor Relations | |
Phone: | +31 7735566 - 00 | |
E-Mail: | ir@qiagen.com | |
Website: | www.qiagen.com | |
ISIN(s): | NL0015001WM6 (Share) | |
Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
Other Stock Exchanges: | NYSE, SIX, BX Swiss |
[ source: https://www.pressetext.com/news/1731064500506 ]
(c) pressetext Nachrichtenagentur GmbH Ad-hoc and financial news distributed by pressetext. Archive: https://www.pressetext.com/channel/Adhoc The emitter is responsible for the content. Contact: adhoc@pressetext.com or +43-1-81140-0.
Keine News verfügbar